CompletedNot Applicable

Clinical Usefulness of Therapeutic Drug Monitoring of Colistin in Patients Treated With Colistin.

South Korea15 participantsStarted 2016-01

Plain-language summary

Clinical usefulness of therapeutic drug monitoring of colistin in patients treated with colistin

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age over 18 years old. * Those who receive colistin therapy for the treatment of multi-drug resistant gram negative bacteria infection. Exclusion Criteria: * Those who received colistin therapy less than 48 hours * Those who received colistin therapy through the bronchus

What they're measuring

AKI

Timeframe: Through study completion, an average of 1 month

Trial details

NCT IDNCT03007290

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-12

View on ClinicalTrials.gov More Multidrug-resistant Gram-negative Bacteria Infection trials